Status:

COMPLETED

Minimal Invasive Treatment of Achilles Tendinopathy: Focus on Percutaneous Release (Maffulli)

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Conditions:

Tendinopathy

Eligibility:

All Genders

Brief Summary

To evaluate the outcome of percutaneous paratenon release for chronic midportion Achilles tendinopathy.

Detailed Description

Since 2011 the percutaneous procedure took the place of the open release of the paratenon for the surgical treatment for chronic midportion Achilles tendinopathy in the investigators' center. In this ...

Eligibility Criteria

Inclusion

  • patients that underwent percutaneous paratenon release for chronic midportion Achilles tendinopathy

Exclusion

  • insertional tendinopathy
  • open intervention
  • (partial) Achilles tendon rupture

Key Trial Info

Start Date :

November 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT04793971

Start Date

November 1 2014

End Date

April 1 2015

Last Update

March 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals of Leuven

Pellenberg, Vlaams-Brabant, Belgium

Minimal Invasive Treatment of Achilles Tendinopathy: Focus on Percutaneous Release (Maffulli) | DecenTrialz